Safety and Efficacy Study of Orally Administered DS102 in Healthy Subjects

NCT02673593 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DS102
DRUG: Placebo

Sponsor

DS Biopharma